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Abstract
Unlike the pandemic form of HIV-1 (group M), group O viruses are endemic in west central
Africa, especially in Cameroon. However, little is known about group O’s genetic evolution,
and why this highly divergent lineage has not become pandemic. Using a unique and large
set of group O sequences from samples collected from 1987 to 2012, we find that this line-
age has evolved in successive slow and fast phases of diversification, with a most recent
common ancestor estimated to have existed around 1930 (1914–1944). The most rapid
periods of diversification occurred in the 1950s and in the 1980s, and could be linked to
favourable epidemiological contexts in Cameroon. Group O genetic diversity reflects this
two-phase evolution, with two distinct populations potentially having different viral proper-
ties. The currently predominant viral population emerged in the 1980s, from an ancient pop-
ulation which had first developed in the 1950s, and is characterized by higher growth and
evolutionary rates, and the natural presence of the Y181C resistance mutation, thought to
confer a phenotypic advantage. Our findings show that although this evolutionary pattern is
specific to HIV-1 group O, it paralleled the early spread of HIV-1 group M in the Democratic
Republic of Congo. Both viral lineages are likely to have benefited from similar epidemiolog-
ical contexts. The relative role of virological and social factors in the distinct epidemic histo-
ries of HIV-1 group O and M needs to be reassessed.
Author Summary
HIV-1 group O is one of the causal agents of AIDS, together with HIV-1 groups M
(responsible for the pandemic), N and P (15 and 2 cases detected respectively, from Cam-
eroon) and HIV-2 groups A to I (mostly found in West Africa), each group resulting from
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a distinct cross species transmission event from non-human primates. Even though mostly
restricted to Cameroon, group O infections have been found in other African countries as
well as in Europe and in the US. Due to their genetic distance from the pandemic HIV-1
group M, group O viruses still impact diagnosis, virological and therapeutic monitoring.
Moreover, very few data are available on the natural history and epidemiology of these
infections, as well as their genetic diversity and evolution. In particular, there is currently
no explanation of the lack of spread of these variants, compared to the pandemic viruses
from group M. Analysis of HIV-1 group O molecular evolution, from sequences spanning
more than 2 decades, is an opportunity to better understand the phylodynamics of group
O infection. We investigate it further by producing the largest set of group O sequences
described. We show that the previous classifications proposed do not agree with each
other and do not fit with the extensive genetic diversity of this group. We also estimate
that group OMRCA existed in the 1930s (95% Higher Posterior Density: 1914–1944), and
show that group O has diversified during two successive phases that could be linked to the
specific historical context of Cameroon. These results contribute to a better understanding
of the factors influencing HIV evolution, especially in the local context of west central
Africa and lead to new hypotheses on the limited diffusion of such variants.
Introduction
Human Immunodeficiency Virus Type 1 (HIV-1) is comprised of four groups (M to P), each
originating from a distinct cross species transmission event from Simian Immunodeficiency
Virus (SIV) variants circulating in apes [1,2,3]. The major group (M) has spread worldwide
from Central Africa during the second part of the 20th century [4,5], while groups N and P are
extremely rare. These latter two groups have arisen more recently and have only been identified
so far in 15 and 2 patients respectively [1], all but one from Cameroon. Finally, despite group
O’s origin being estimated to be about the same time period as group M [6], the group O (out-
lier) epidemic is mostly restricted to Cameroon, and has remained stable since the 1990s,
whereas group M has been spreading dramatically [7,8,9].
Little is known about natural history of group O infection, but the limited follow-up data
available [7,10] indicate that, as with group M, horizontal as well as vertical transmission con-
tributes to its spread, and untreated patients show high plasma viral load, leading to a loss of
CD4 T cells and eventual progression to AIDS. Thus, the natural history of group O infection
seems to be similar to that of group M, even though some studies have shown distinct virologi-
cal properties such as a lower replication capacity [11,12] or failure to counteract some cellular
restriction factors [13,14].
There is high genetic distance between M and O strains, with 67%, 73% and 56% sequence
identity between group M HXB2 [15] and O ANT70 [16] prototype strains in gag, pol, and env
genes, respectively. As a result, diagnosis and follow-up of group O infections require adapted
tools [1]. Group O natural polymorphism also has an impact on treatment options, since most
strains naturally present the Y181C mutation in the Reverse Transcriptase (RT) conferring
resistance to Efavirenz and Nevirapine (first generation Non Nucleoside RT Inhibitors,
NNRTIs). Of particular note, these molecules are part of the most common first line antiretro-
viral therapy combinations used in Cameroon. Taken together, these group O characteristics
can lead to delayed diagnosis, underestimated viral loads or treatment failure, if the nature of
the group O infection status is not taken into account.
The Two-Phase Emergence of HIV-1 Group O in Cameroon
PLOS Pathogens | DOI:10.1371/journal.ppat.1005029 August 4, 2015 2 / 13
Not only is group O highly distant from group M, but over nearly a century since its intro-
duction into the human population, a high level of intra-group genetic diversity has developed
and several attempts have been made to characterize it. Different classifications have been pro-
posed, and these have defined 3 clades [17,18], 5 clusters [19] and more recently, only 2 line-
ages (C181 or Y181) based on the residue at the RT position 181 [20]. The relevance of these
different classifications, which were based on few sequences and never compared to each other,
needs to be evaluated. More importantly, the processes that led to this apparent complexity are
still to be understood.
No significant group O epidemic has been described outside Cameroon, and only sporadic
cases appear in other African countries (mostly west central Africa), in the US and in Europe
[1]. In France, the RES-O survey network has identified 143 patients infected with group O
since 1992 [10,21], the largest series of group O infections identified outside of Cameroon.
Most of these patients originate or are linked to patients originating from Cameroon, due to
historical links between France and this region.
This absence of epidemic spread outside of the Cameroon is surprising, since group O infec-
tions have been identified on three different continents, as far back as 20 years ago in North
America and 50 years ago in Western Europe, and an estimated presence close to a century old
in Africa. Interestingly, it has recently been proposed that group M expansion in the capital of
the Democratic Republic of Congo (DRC) Kinshasa had benefited from different contextual
changes in the 1960s, leading to a dramatic increase of the number of infections at that time
[5]. The authors did not observe such a change in group O growth rate, thus hypothesising that
this explained the different epidemiological histories of groups M and O.
Here we have used the largest set of HIV-1 group O sequences assembled to date, obtained
from 190 patients sampled in France or in Cameroon on a time scale of 26 years, to better
understand group O emergence and evolution, by investigating the dynamics of their diversifi-
cation and its consequences.
Results
The maximum likelihood tree obtained from 190 concatenated sequences showed that a large
proportion of the strains fall in a major subgroup. The short branch lengths in this major sub-
group when compared to the long ones in the minor subgroup (S1 Text and S1 Fig) give the tree
a comet-like shape (Fig 1A), as opposed to the well-defined double star structure of the pan-
demic group M subtypes (Fig 1B). Due to this particular topology, we defined the major sub-
group (N = 147) as corresponding to the "comet head" or H strains, and the minor subgroup
(N = 43), as corresponding to the "comet tail" or T strains. Subclusters could be observed among
the H strains (H1, H2 and H3) and the T strains (T1 and T2). This classification encompasses
the previous ones that were partially discordant (see S2 Text and S2A and S2B Fig).
We used 154 sequences for which all three gene fragments were obtained from a single sam-
ple of known sampling time to investigate group O origins and dynamics over time. Different
coalescent population growth models (constant size, exponential growth, logistic growth and
Bayesian skyline) gave consistent estimates for group O’s time to most recent common ances-
tor (tMRCA) of around 1930 (Fig 2, black curves), with 95% highest posterior densities (95%
HPD) ranging from 1914 to 1944. Interestingly, Bayesian Skyline Plots showed that group O
genetic diversity had gone through an alternation of slow and fast growth phases (Fig 3A). Two
waves of exponential growth were observed, the first around 1950 and the second, longer and
more important, starting in the late 1970's and ending in the early 1990s. While the first wave
could be observed when investigating all of the 154 sequences (Fig 3A), it did not appear when
only including the H strains and the two minor subclusters observed among the T strains, T1
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and T2 (Fig 3B). These results indicate that the first wave represents the development of an
ancestral level of genetic diversity, and the second wave the emergence of subpopulations such
as H strains.
We then investigated the date of subgroup HMRCA using the same 4 growth models,
which consistently gave an MRCA estimated around 1945 (best fitting model 95% HPD: 1933–
1955) (Fig 2, green curves). This suggests that H strains MRCA was present among the back-
ground of genetic diversity that had arisen during the first exponential growth phase in the
1950s. Among these H strains, we observed some important and strongly supported subclus-
ters H1, H2, H3, which all together represented 34% of the group O strains studied herein.
Their respective MRCA estimates were even more recent, all being estimated to have appeared
between 1975 and 1980 (Fig 2, blue, red and yellow curves), the very beginning of the second
exponential growth phase.
When studying the distribution of the Y181C resistance mutation among the 100 samples
collected from NNRTI-naïve patients (77 H strains, 23 T strains), we observed that this profile
was naturally present in 65 strains (65%), 62 of which were H strains and only 3 T strains.
Thus, 80.5% of the H strains naturally presented the resistance mutation and only 13% of the T
strains, indicating a strong association between subgroup H and C at position 181 (Chi-
squared test: p<10E-5). Moreover, among the 15 H strains presenting a 181Y residue, 11
(73.3%) belonged to a single subcluster (H3).
Bayesian analyses indicated that the mean evolutionary rate of H strains was significantly
higher than that of the T strains (Student T test: p<10E-5; see Table 1). For both subgroups,
the dN/dS ratios indicated a globally negative selection pressure on the genome regions
Fig 1. Phylogenetic analysis of HIV-1 sequences. a)Maximum likelihood tree inferred from the 190 concatenated group O sequences, with white
diamonds at nodes with bootstrap values >70 and colours highlighting the nature of the residue at position 181 in the Reverse Transcriptase: Pink = C
(N = 116); Green = Y (N = 71); Blue = mixed Y and C (N = 3); Grey = sequences from patients non NNRTI-naïve or with no data about NNRTI treatment. b)
Maximum likelihood tree inferred from the 190 concatenated group M sequences.
doi:10.1371/journal.ppat.1005029.g001
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investigated, with this ratio was also significantly higher in subgroup H than in subgroup T
(Likelihood Ratio Test: p = 7.10E-4, see Table 1). Thus, H strains evolved at a higher rate and
had lower negative selection pressure than T strains. Evolutionary analyses also indicated that
the mean growth rate of subgroup H was significantly higher than that of the T (Student T test:
p<10E-5; see Table 1), consistent with the apparent predominance of the H strains.
Discussion
Even though both HIV-1 groups O and M’s MRCAs have been estimated in the early 20th cen-
tury, group O, unlike group M, has not spread globally and remains endemic in Cameroon.
The causes of this are not fully understood: unlike HIV-1 groups N and P, group O has been
successful enough to infect tens to hundreds of thousands people [3,18] and no evidence of
lower transmissibility has been shown in vivo, as it has been for HIV-2 [27]. Thus, aside from
potential intrinsic properties [11,12], epidemiological and related contextual factors could also
have played a role in this difference between the two main HIV-1 lineages [5].
Our data confirmed that group O diversification represents a continuum of diversity consis-
tent with local diversification in a geographically restricted area (see S2 and S3 Texts and S2
Fig), while the group M subtypes are mostly the result of founder effects following the intro-
duction of single strains to dispersed geographic locations [28]. We also confirmed the
Fig 2. Estimates of group O tMRCA. The marginal posterior density curves obtained using four different population growth models are shown. Different
colours identify the distribution of tMRCA estimates for global group O (black), subgroup H (green), and subclusters H1, H2 and H3 (blue, red and yellow,
respectively).
doi:10.1371/journal.ppat.1005029.g002
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Fig 3. Dynamics of group O populations over time and contemporaneous contextual elements in Cameroon. a) Bayesian Skyline Plot (BSP) inferred
from the 154 concatenated group O sequences for which the three genome regions were obtained from a single time-point sample. b) BSP inferred from a
subset of these sequences (N = 137), including the H strains (N = 124) and clusters T1 (N = 6) and T2 (N = 7) from the T strains. c) Periods of high viral
growth rates for HIV-1 group M CRF02_AG [22] (dark gray box), HIV-1 group O (grey boxes), HCV-1 [23] (dark pink box), HCV-2 [23] (pink box) and HCV-4
[23] (brown box) in Cameroon; cohort with high HCV seroprevalence in Cameroon [24] (orange box); population-scaled risk factors for iatrogenic
transmission during trypanosomiaisis control campaigns in rural Cameroon [25] (peak period: dark blue box), pentamidine prophylaxis campaigns in rural
Cameroon [25,26] (blue box) and intra-venous treatment for yaws and syphilis in Cameroon [25] (peak period: light blue box).
doi:10.1371/journal.ppat.1005029.g003
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existence of a predominant population (H strains—from the comet Head), which was strongly
associated to the C mutation at the Reverse Transcriptase position 181, but our data demon-
strated that this mutation alone is not an adequate marker for classification as proposed by
Tebit et al. [20]. Indeed, it was not possible to just split the tree in two C181 and Y181 subpopu-
lations, even if hypothesizing unlikely transmissions of strains with acquired mutations for the
few T strains harbouring this Y181C mutation.
The existence of this major subgroup raised questions on the evolutionary processes that
could have shaped the particular tree topology. Our estimation of group OMRCA around
1930 (95% HPD: 1914–1944) is close to the previous estimates of 1920 [6] which was based on
fewer sequences. This result confirms that group OMRCA was contemporaneous to that of
group M, estimated in the beginning of the 20th century [4]. But unlike recent conclusions of a
constant low growth rate for group O by Faria et al. [5], we show two phases of exponential
growth, the first during the 1940–1960 time window and the second one during 1970–1990.
The causes for these two phases are probably complex and multifactorial. However, the
increase in growth rates around 1950 coincides with a period of high-rate of transmission of
HCV in Cameroon, as shown in both epidemiological [24] and phylogenetic studies [23], (Fig
3C). In Southern Cameroon, HCV infection is a reliable marker of iatrogenic transmission,
associated in elderly people with a history of exposure to medical campaigns and interventions
involving unsterile procedures [29]. The 1940–1960 period saw a rise in injection practices
globally [30]. Colonial medical activity in Cameroon peaked during this period, and was dis-
mantled after independence (1960) for political and epidemiological reasons (low incidence of
sleeping sickness and yaws) [25]. Since the first plateau identified in this study matches the
decline of HCV transmission in Cameroon after 1960, the first phase of group O rapid growth
can thus reflect a scenario of iatrogenic amplification following an event of cross-species trans-
mission, as proposed for HIV-1 M in the Congo basin region [31,32]. The booming city of
Douala may have been a favorable epidemic context—combining iatrogenic and socio-sexual
factors—for the initial diversification of group O. Indeed, this is most probably where a visiting
Table 1. Comparison of rate and ratio estimates between H and T subgroups.
Mean* 95% HPD$ / 95%CI£ p#
Evolutionary rate H 1,50E-03 [1,21E-03; 1,80E-03] <10E-05
T 1,14E-03 [8,64E-04; 1,44E-03]
Growth rate H 1,20E-01 [9,38E-02; 1,47E-01] <10E-05
T 6,14E-02 [3,68E-02; 8,69E-02]
dN/dS H 2,94E-01 [2,82E-01; 3,06E-01] 7,40E-04
T 2,43E-01 [2,29E-01; 2,58E-01]
* the mean value for evolutionary and growth rates were estimated using BEAST, under the best ﬁtting
model (GTR+Γ+I and exponential growth); the mean values for the Non Synonymous (dN) versus
synonymous (dS) mutation ratios were estimated using HyPhy under the GTR model.
$ the 95% Higher Posterior Densities (HPD) upper and lower bound for evolutionary and growth rates were
estimated using BEAST, under the best ﬁtting model (GTR+Γ+I and exponential growth).
£ the 95% conﬁdence intervals (CI) for the Non Synonymous (dN) versus synonymous (dS) mutation ratios
were estimated using HyPhy under the GTR model.
# the p-value for the difference between two means was calculated using student T test; the Likelihood
Ratio Test p-value against the hypothesis of a single rate was estimated using HyPhy under the GTR
model.
doi:10.1371/journal.ppat.1005029.t001
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Norwegian sailor—the first reported case of group O infection—became infected in 1962
[33,34], suggesting that the virus was established in this city by the early 1960s.
Two decades later, the greater and longer second phase of exponential growth started in the
late 1970's and reached a plateau in the early 1990s. Though group O might have found a
favourable social context for transmission during this period, urban growth per se cannot
explain the exponential increase in new infections, since rates of urban growth in Yaoundé and
Douala were maximal in the post-second war years (at about 10%) and have declined since,
down to 5–7% in the 2000’s [35,36,37,38]. Further investigations are thus needed to understand
this second phase of diversification. Intrinsic viral properties could have been involved, since
the second wave of diversification is linked to the development of several viral subpopulations,
some minor in the T subgroup (T1 and T2), and the H strains which became predominant. Of
note, subclusters H1, H2 and H3, which MRCA was estimated to be no older than 1975, now
represent 34% of the strains included in this study. They have been sampled either in Camer-
oon or in France, at time points ranging from 1994 to 2012, showing that they are not associ-
ated to a particular sampling time or location (see S2 Text and S2C and S2D Fig). Selection
pressure analysis also showed that H strains were submitted to lower negative selection pres-
sure than T strains and evolved faster. It has also been proposed that the 181C residue in the
RT could represent a fitness advantage [20], even though this has been demonstrated in vitro
only using mutants viruses from a H strain backbone. The reasons why H strains became pre-
dominant could thus be linked to favourable biological properties of these strains and/or differ-
ent opportunities for diffusion. The two phases may also reflect a two-step geographic
expansion of the virus in Cameroon, but the absence of a geolocalized dataset does not allow us
to investigate this hypothesis further.
Our data thus show that group O genetic diversity and phylogenetic topology are due to
their evolution in alternating slow and fast phases that could be related to specific events in the
history of Cameroon, contrasting with recent conclusions [5]. However, these variants failed to
become pandemic despite two exponential growth phases. Interestingly, the end of the last
exponential phase coincides with the time of introduction and spread of CRF02_AG, the pre-
dominant group M form in Cameroon, after it originated in the 1970's in the DRC [22] (Fig
3C). This led to the previous observation in Cameroon of a drop in group O infections among
HIV-1 positive samples in the early 1990s, when the M group rose exponentially while group
O remained stable or even slightly decreased [8,9]. How group M became predominant over
the group O epidemic in Cameroon could be due to different virological properties [11,12]
and/or a competition between the two epidemics, as suggested for HIV-2 in West Africa [39].
This would also explain the absence of French group O epidemic (see our phylogeographic
analyses in S2 Text and S2C Fig), contrasting with HIV-1 group Mmolecular epidemiology.
Most of the 143 group O patients identified originate from Cameroon, while after the long pre-
dominance of group M subtype B in France, non-B strains have been imported from sub-Saha-
ran Africa and now circulate in patients from various risk groups [40]. Thus, the absence of
diffusion of group O in France has to be explained by other factors than a lack of boundaries
between different epidemiological populations.
In summary, our results on group O genetic diversity support the conclusion that it cannot
be divided into subtypes similar to group M, but a major subgroup (H) emerged from a geneti-
cally diverse minor subgroup (T). Contrary to Faria's findings [5], these two populations reflect
the fact that group O underwent two waves of rapid diversification in the 20th century.
Although this evolutionary pattern is specific to group O, the HIV-1 group O epidemic in
Cameroon paralleled the spread of HIV-1 group M in the DRC. This is certainly linked to simi-
lar factors as those described for group M, such as iatrogenic amplification and the favorable
urban context of fast-growing and cosmopolitan cities. In this light, the emergence of group M
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in Kinshasa may be seen as unexceptional, however expansion of groups O and M occurred in
distinct epidemiological and socio-demographic contexts in Cameroon and the DRC respec-
tively, which could have led to their different epidemiological patterns [2].
While our study reveals important information about HIV-1 group O’s emergence and evo-
lution, investigations are still needed to understand the other reasons for their unsuccessful
spread compared to that of group M—as well as for group O T strains compared to that of H
strains—especially by exploring the biological properties of these divergent viruses.
Materials and Methods
Patients and samples
Samples from 190 patients were included in the analysis, 102 of which were sampled in France,
87 in Cameroon, and 1 in Gabon. The time of sampling spanned from June 1987 to February
2012, but was undetermined for 4 samples.
In France, the samples were collected from hospitals located all across the country by the
RES-O survey of the French HIV National Reference Centre in Rouen. In Cameroon, samples
were collected at the Centre Pasteur du Cameroun from different parts of the country: Centre
(N = 25), Littoral (N = 7), North (N = 4), and South (N = 1) regions. For 50 samples, the collec-
tion site in Cameroon was not determined. The sample from Gabon was collected in Libreville.
The nature of the samples analyzed was plasma or serum (N = 173), PBMCs (N = 6) or
supernatant from viral culture (N = 11).
Ethics statement
The viral sequences we analyzed were produced from leftover samples that had previously
been collected for routine diagnosis or follow up of the patients. Thus, no additional sample
was performed specifically for this study, and we did not use any information about the
patients from whom this samples had been obtained. As a consequence, no consent from the
patients nor approvement from ethics committee was requested.
Genome amplification and sequencing
Three fragments from two genes (prRT: pol protease and partial RT, 987 bp; int: pol partial
integrase, 603 bp, gp41: env partial gp41, 522 bp) were amplified by nested PCR or RT-PCR,
depending on the sample type, and sequenced as previously described [41]. Accession Num-
bers: KT198045—KT198614.
Genetic diversity
Phylogenetic analyses. Sequences of three gene fragments from the 190 strains were
codon-aligned using MUSCLE in MEGA 5.0 [42]. In env gp41, a small hypervariable region
with insertions, corresponding to the loop between HR1 and HR2, could not be unambiguously
aligned and was thus removed. Maximum likelihood phylogenetic trees were inferred from
each of the three alignments, as well as from a concatenated alignment of the three regions,
using RAxML [43] rapid hill-climbing algorithm on randomized stepwise addition parsimony
trees. A General Time Reversible model with Gamma-distributed evolutionary rates among
sites (GTR+Γ) was used to compute 200 candidate ML phylogenetic trees for each gene align-
ment. Of these, the tree with the highest likelihood was selected, and a 1000-replicate paramet-
ric bootstrap analysis was performed to assess the reliability of branching order. The ML trees
were visualised using FigTree (http://tree.bio.ed.ac.uk/software/figtree/).
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Distribution of the natural Y181C mutation. Among the 190 concatenated sequences,
11 were sampled from patients who received or had received NNRTIs and 100 were NNRTI-
naïve at the time of sampling. The information about NNRTI treatment was not available for
the other 79 patients. To investigate the distribution of the natural 181C resistance mutation,
we used the sequences from the 100 NNRTI-naïve patients and studied the association between
clade and Y181C residue by using a chi-squared test.
Evolutionary analyses. Out of the 190 concatenated sequences described above, 154 were
used for tMRCA inference and analysis of evolutionary dynamics. These were the sequences for
which all three regions had been sequenced from the same sample, meaning a unique time of
sampling. All the positions in the protease and RT regions known to be involved in drug resis-
tance for group M according to the ANRS algorithm (http://www.hivfrenchresistance.org/)
were removed from the alignment. SIV sequences sampled from gorillas (accession numbers:
FJ424863, FJ424864, FJ424865, FJ424866, FJ424871) were included to be used as an outgroup,
and evolutionary analysis was performed in a Bayesian framework using BEAST [44]. A GTR
+Γmodel allowing for invariant rates among sites was used, with a log-normal relaxed molecu-
lar clock model and analysis performed using various tree priors, including constant size, expo-
nential growth, logistic growth and Bayesian Skyline. Bayesian analysis was calibrated by
setting priors on the tip nodes of the tree, referring to the year in which sequences were sam-
pled. As a measure of reliability between the different tree priors, Bayes' factors were calculated,
representing the ratio of the marginal likelihood between each of the pairs of models. Addition-
ally, for Bayesian skyline analysis, effective population size growth rate was estimated over
time, for the tree as a whole, as well as for selected clusters in the tree, and visualised using
Bayesian skyline plots in Tracer.
Estimation of selection pressure. The ratio of non-synonymous versus synonymous
mutations (dN/dS) was estimated with HyPhy [45] on the 190 concatenated sequences, with
the protease and reverse transcriptase codons involved in ARV resistance removed. The ML
phylogenetic tree was divided into two partitions (H and T strains), and estimation of the dN/
dS ratios of the resulting clusters was performed by running the SelectionLRT analysis with a
GTR model.
Supporting Information
S1 Text. Genetic distance. Comparison of mean group O and group M genetic distances
observed intra- and inter-subgroups.
(DOC)
S2 Text. Phylogenetic exploration. Evaluation of the previous classifications, and distribution
of the strains depending on their sampling time and location.
(DOC)
S3 Text. Recombination analyses. Evaluation of the recombination signal in our dataset.
(DOC)
S1 Fig. Mean group O and group M genetic distances, intra- and inter- subgroups. The
mean pairwise uncorrected p-distances observed within each group O subgroup (black) was
compared to that observed in each group M subtype (light grey), as well as the mean intra-sub-
type and the mean inter-subtype distances observed for group M (dark grey).
(PDF)
S2 Fig. Phylogenetic analysis of HIV sequences. a)Maximum likelihood tree inferred from
the 190 concatenated group O sequences, with bootstrap values>70 (same tree as main text
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Fig 1) and colours highlighting the previous nomenclature from [18]: Blue = clade A
(N = 146); Red = clade B (N = 7); Green = clade C (N = 10); Black = not classified (N = 26). b)
Same tree as (a) with colours highlighting the previous nomenclature from [19]: Blue = cluster
I (N = 111); Red = cluster II (N = 7); Green = cluster III (N = 10); Yellow = cluster IV (N = 7);
Pink = cluster V (N = 4); Black = not classified (N = 51). Due to the partial sequences available
from [19], it was not possible to include them in the concatenated alignment; the identification
of the clusters was thus made using a env gp41 tree involving our strains and those from [19],
see S3 Fig. c) same tree as (a), with colours highlighting the sampling country: Blue = France
(N = 102); Red = Cameroon (N = 87): Green = Gabon (N = 1). d) Same tree as (a) with colours
highlighting the time of sampling: Blue = 1987–1997 (N = 38); Green = 1997–2002 (N = 39);
Orange = 2003–2007 (N = 38); Red = 2007–2012 (N = 39); Grey = ND or different sampling
time in the different regions (N = 36).
(PDF)
S3 Fig. Phylogenetic analysis of 360 HIV-1 Group O partial gp41 sequences (513 nucleo-
tides).Maximum likelihood tree inferred using MEGA 5.0 with a GTR+Γ+I model; 1000 Boot-
strap replicates were performed, and bootstrap values higher than 70% are indicated. Symbols
highlight the sequences previously included in [19] and the cluster they were assigned to:
Blue = cluster I (triangle: subcluster Ia, round: subcluster Ib, square: subcluster Iu);
Red = cluster II; Green = cluster III; Yellow = cluster IV; Pink = cluster V; Black: unclassified.
(PDF)
S4 Fig. Phylogenetic analysis of HIV-1 group O individual region sequences. a)Maximum
likelihood tree inferred from the 190 protease and partial Reverse Transcriptase group O
sequences, with colours highlighting the previous nomenclature from [18]: Blue = clade A
(N = 146); Red = clade B (N = 7); Green = clade C (N = 10); Black = not classified (N = 26).
Sequences belonging to population H are indicated. b) Same tree as (a) from the 190 integrase
sequences. c) same tree as (a), from the 190 gp41 sequences.
(PDF)
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